The Mirai AI model significantly improves detection of interval breast cancers in negative screening mammograms.
Key Details
- 1Mirai risk model analyzed 134,217 screening mammograms, including 524 interval cancers.
- 2Top 20% risk group by Mirai captured 42.4% of interval cancers, corresponding to 1.7 additional detections per 1,000 exams.
- 3AUC values for interval cancer prediction ranged from 0.67 to 0.72 across time, age, and breast density subgroups.
- 4No significant performance variation across different age groups or breast densities was observed.
- 5Mirai has been validated on nearly 2 million mammograms across 21 countries.
- 6Editorial comments highlight progress but note limitations since interval cancer detection did not surpass 50%.
Why It Matters

Source
AuntMinnie
Related News

AI and Collaborative Strategies Advance Lung Cancer Screening Uptake
Collaborative initiatives and novel AI tools are helping to advance lung cancer screening, but participation barriers and disparities persist despite guideline expansions.

AI Advances Push Opportunistic Imaging Into Clinical Focus
AI-powered opportunistic screening is transforming routine radiological images into proactive tools for risk detection of major diseases.

AI Improves Chest CT Workflow and Reduces Radiation Without Compromising Quality
AI-driven automatic positioning in chest CT reduces radiation dose and improves workflow efficiency without affecting image quality.